Smart Soil Management System

Publication ID: 24-11857671_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Smart Soil Management System,” Published Technical Disclosure No. 24-11857671_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857671_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,671.

Summary of the Inventive Concept

A novel system utilizing subcutaneous implantable devices with non-homogenous matrices to monitor and control soil moisture levels, optimize crop yields, and improve water conservation in agricultural fields and urban landscaping.

Background and Problem Solved

Current methods for soil moisture monitoring and control are often inefficient, leading to overwatering, water waste, and reduced crop yields. The original medical implant patent, while effective in addressing the issue of initial drug 'burst' in medical implants, did not consider applications in agriculture. This inventive concept addresses the need for a more efficient and targeted approach to soil management, leveraging the core technology of the original patent.

Detailed Description of the Inventive Concept

The Smart Soil Management System consists of subcutaneous implantable devices adapted for subterranean deployment, featuring a matrix with a non-homogenous mixture of at least two different types of materials for releasing water and nutrients to the soil. These devices can be implanted in agricultural fields, greenhouses, or urban landscaping to monitor soil moisture levels and adjust the release of water and nutrients accordingly. The system can be used to optimize crop yields, detect and prevent fungal growth, and improve water conservation.

Novelty and Inventive Step

The new claims introduce a novel application of the original patent's core technology to the field of agriculture, providing a non-obvious solution to the problem of inefficient soil management. The use of subcutaneous implantable devices with non-homogenous matrices in soil management is unprecedented and offers a significant improvement over existing methods.

Alternative Embodiments and Variations

Alternative embodiments of the Smart Soil Management System could include devices with varying matrix compositions, sizes, and shapes to accommodate different soil types, crops, and environmental conditions. Variations could also include integration with other agricultural technologies, such as precision farming tools or drones, to further enhance the system's efficiency and effectiveness.

Potential Commercial Applications and Market

The Smart Soil Management System has significant commercial potential in the agricultural industry, with potential applications in precision agriculture, crop yield optimization, and water conservation. The market for this technology is vast, with potential customers including farmers, agricultural companies, and government agencies focused on sustainable agriculture and water management.

CPC Classifications

SectionClassGroup
A A61 A61K9/0024
A A61 A61K31/4468
A A61 A61K31/485
A A61 A61K45/06

Field of Art

Medical device engineering and drug delivery systems, with expertise in implantable matrix technologies for controlled substance release, encompassing pharmaceutical, biotechnology, and medical device design

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degree (MS/PhD) in biomedical engineering, materials science, or pharmaceutical sciences, having 3-5 years experience designing controlled-release implantable devices, familiar with matrix composition techniques and cross-domain technology adaptation

Obviousness Rationale

A PHOSITA would recognize the fundamental principles of non-homogenous matrix drug delivery are directly transferable across technical domains, with the agricultural application representing a predictable extension of the original medical implant technology. The core innovation of controlled substance release through matrix engineering remains consistent between medical and agricultural contexts. The technical mechanisms for modulating release rates and preventing burst effects are substantively identical when applied to water/nutrient delivery versus pharmaceutical compounds.

Obvious Combinations & Variations

Source Patent Element
Non-homogenous matrix with multiple drug materials for controlled release
PTD Variation
Non-homogenous matrix with water and nutrient materials for controlled soil delivery
Obviousness Reasoning
Predictable application of known controlled-release matrix technology to a related technical domain with foreseeable design adaptations
Source Patent Element
Subcutaneous implantable device with coating to modulate release characteristics
PTD Variation
Subterranean implantable device with protective coating for soil environment interaction
Obviousness Reasoning
Known technique of protective coating adaptation to manage environmental interaction, representing standard engineering design choice
Source Patent Element
Method of reducing initial delivery burst through matrix composition
PTD Variation
Method of preventing excessive moisture release through matrix engineering
Obviousness Reasoning
Directly analogous approach to managing substance release using established matrix heterogeneity principles
Source Patent Element
Multiple therapeutic compounds integrated into single matrix
PTD Variation
Multiple nutrients/water management compounds integrated into agricultural device matrix
Obviousness Reasoning
Straightforward extension of multi-compound matrix design principles across technical domains
35 U.S.C. § 103 Summary: Based on US Patent 11857671's teachings of non-homogenous matrix implantable drug delivery systems, the present disclosure demonstrates that a Person Having Ordinary Skill In The Art would find the agricultural matrix delivery system obvious, as the fundamental controlled-release mechanisms are directly transferable across technical domains with minimal inventive modification.

Original Patent Information

Patent NumberUS 11,857,671
TitleMedical implant